{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:37:12Z","timestamp":1782286632255,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.canlet.2009.12.014","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T12:26:41Z","timestamp":1263558401000},"page":"31-40","source":"Crossref","is-referenced-by-count":40,"title":["GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro"],"prefix":"10.1016","volume":"293","author":[{"given":"Szabolcs","family":"Bellyei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Schally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zarandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozsef L.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Vidaurre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Pozsgai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2009.12.014_bib1","first-page":"3354","article-title":"Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development","volume":"6","author":"Hong","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.12.014_bib2","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-04-4109","article-title":"Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model","volume":"65","author":"Vantyghem","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.12.014_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-006-9222-z","article-title":"GnRH analogs reduce invasiveness of human breast cancer cells","volume":"100","author":"von Alten","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2009.12.014_bib4","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2009.12.014_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09513599909167587","article-title":"LH\u2013RH analogues: I. Their impact on reproductive medicine","volume":"13","author":"Schally","year":"1999","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.canlet.2009.12.014_bib6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.neo.7900074","article-title":"Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice","volume":"2","author":"Kiaris","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2009.12.014_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1006363230990","article-title":"Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice","volume":"60","author":"Kahan","year":"2000","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2009.12.014_bib8","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1210\/jc.2004-2179","article-title":"Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone","volume":"90","author":"Engel","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2009.12.014_bib9","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1073\/pnas.0410006102","article-title":"Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+ dependent pathway","volume":"102","author":"Rekasi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ncpendmet0677","article-title":"Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer","volume":"4","author":"Schally","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2009.12.014_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1043-2760(99)00209-X","article-title":"Antagonistic analogs of growth hormone-releasing hormone: new potential antitumor agents","volume":"10","author":"Schally","year":"1999","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2009.12.014_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/1097-0045(20001001)45:2<158::AID-PROS10>3.0.CO;2-K","article-title":"Peptide analogs in the therapy of prostate cancer","volume":"45","author":"Schally","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2009.12.014_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/frne.2001.0217","article-title":"Hypothalamic hormones and cancer","volume":"22","author":"Schally","year":"2001","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.canlet.2009.12.014_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1043-2760(02)00613-6","article-title":"Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis","volume":"13","author":"Frohman","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2009.12.014_bib15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s00018-004-3434-3","article-title":"New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs","volume":"61","author":"Schally","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2009.12.014_bib16","doi-asserted-by":"crossref","first-page":"17424","DOI":"10.1073\/pnas.0506844102","article-title":"The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues","volume":"102","author":"Havt","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib17","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/sj.bjc.6604386","article-title":"Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines","volume":"98","author":"Barabutis","year":"2008","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2009.12.014_bib18","doi-asserted-by":"crossref","first-page":"14894","DOI":"10.1073\/pnas.96.26.14894","article-title":"Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma","volume":"96","author":"Kiaris","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib19","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1517\/13543784.12.8.1385","article-title":"Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists","volume":"12","author":"Kiaris","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.canlet.2009.12.014_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00001813-200110000-00008","article-title":"Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone","volume":"12","author":"Chatzistamou","year":"2001","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canlet.2009.12.014_bib21","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1210\/jc.86.5.2144","article-title":"Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice","volume":"86","author":"Chatzistamou","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2009.12.014_bib22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.10865","article-title":"Inhibition of proliferation in human MNNG\/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II","volume":"95","author":"Braczkowski","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2009.12.014_bib23","doi-asserted-by":"crossref","first-page":"11866","DOI":"10.1073\/pnas.182433099","article-title":"The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas","volume":"99","author":"Busto","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/ENDO:18:1:85","article-title":"Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells","volume":"18","author":"Zeitler","year":"2002","journal-title":"Endocrine"},{"key":"10.1016\/j.canlet.2009.12.014_bib25","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.1073\/pnas.0504163102","article-title":"Antagonists of growth hormone-releasing hormone cross the blood\u2013brain barrier: a potential applicability to treatment of brain tumors","volume":"102","author":"Jaeger","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/1078-0432.49.11.1","article-title":"Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice","volume":"11","author":"Stangelberger","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.12.014_bib27","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1073\/pnas.180313097","article-title":"Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone","volume":"97","author":"Halmos","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib28","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1073\/pnas.0610860104","article-title":"Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel","volume":"104","author":"Buchholz","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10495-006-0486-x","article-title":"Inhibition of cell death by a novel 16.2 kD heat shock protein predominantly via Hsp90 mediated lipid rafts stabilization and Akt activation pathway","volume":"12","author":"Bellyei","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2009.12.014_bib30","doi-asserted-by":"crossref","first-page":"10561","DOI":"10.1073\/pnas.180313297","article-title":"Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers","volume":"97","author":"Rekasi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib31","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.ejca.2006.03.027","article-title":"Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody","volume":"42","author":"Schulz","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2009.12.014_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1073\/pnas.012590999","article-title":"Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs","volume":"99","author":"Kiaris","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ygyno.2007.04.016","article-title":"Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo","volume":"106","author":"Yu","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2009.12.014_bib34","article-title":"Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway","author":"Shen","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2009.12.014_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-009-0612-6","article-title":"Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells","author":"Su","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2009.12.014_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/07357900802146154","article-title":"Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene","volume":"26","author":"Li","year":"2008","journal-title":"Cancer Invest."},{"key":"10.1016\/j.canlet.2009.12.014_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2407-6-181","article-title":"Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression","volume":"6","author":"Larkins","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2009.12.014_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00001813-200101000-00010","article-title":"In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses","volume":"12","author":"Arencibia","year":"2001","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canlet.2009.12.014_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2009.12.014_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.suronc.2006.10.002","article-title":"The metastatic cascade in prostate cancer","volume":"15","author":"Arya","year":"2006","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.canlet.2009.12.014_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/138620706776055449","article-title":"Antagonists of growth hormone-releasing hormone in oncology","volume":"9","author":"Schally","year":"2006","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.canlet.2009.12.014_bib42","first-page":"1724","article-title":"Antagonists of growth hormone\u2013releasing hormone (GH\u2013RH) inhibit IGF-II production and growth of HT-29 human colon cancers","volume":"82","author":"Szepeshazi","year":"2000","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2009.12.014_bib43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0959-8049(99)00230-0","article-title":"Antagonists of growth hormone\u2013releasing hormone (GH\u2013RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours","volume":"36","author":"Szepeshazi","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2009.12.014_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ijc.10221","article-title":"Inhibition of PC-3 human prostate cancers by analogs of growth hormone\u2013releasing hormone (GH\u2013RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity","volume":"98","author":"Plonowski","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2009.12.014_bib45","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/sj.onc.1208192","article-title":"Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB","volume":"24","author":"Wei","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2009.12.014_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/cvr\/cvp090","article-title":"Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart","volume":"83","author":"Granata","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.canlet.2009.12.014_bib47","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1038\/ncb0402-e101","article-title":"Intercellular adhesion, signalling and the cytoskeleton","volume":"4","author":"Jamora","year":"2002","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.canlet.2009.12.014_bib48","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1073\/pnas.92.19.8813","article-title":"Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex","volume":"92","author":"Rimm","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.12.014_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bjps.2004.12.025","article-title":"Invasion and metastasis markers in cancers","volume":"58","author":"Chin","year":"2005","journal-title":"Brit. J. Plast. Surg."},{"key":"10.1016\/j.canlet.2009.12.014_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0092-8674(91)90143-M","article-title":"Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role","volume":"66","author":"Vleminckx","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2009.12.014_bib51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P","article-title":"Beta-catenin signaling and cancer","volume":"21","author":"Morin","year":"1999","journal-title":"Bioessays"},{"key":"10.1016\/j.canlet.2009.12.014_bib52","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1038\/sj.onc.1203839","article-title":"Down modulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression","volume":"19","author":"Bagnoli","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2009.12.014_bib53","first-page":"5870","article-title":"Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity","volume":"60","author":"Bender","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.12.014_bib54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0002-9440(10)64031-X","article-title":"Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas","volume":"158","author":"Wiechen","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2009.12.014_bib55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2009.12.014_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/47520","article-title":"Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase","volume":"403","author":"Rossi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2009.12.014_bib57","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0959-8049(00)00156-8","article-title":"Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis","volume":"36","author":"Curran","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2009.12.014_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2144\/05381RV01","article-title":"Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors","volume":"38","author":"Snoek-van Beurden","year":"2005","journal-title":"Biotechniques"},{"key":"10.1016\/j.canlet.2009.12.014_bib59","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.canlet.2009.12.014_bib60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/bcr65","article-title":"Metalloproteinases: role in breast carcinogenesis, invasion and metastasis","volume":"2","author":"Duffy","year":"2000","journal-title":"Breast Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509007307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509007307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T15:58:44Z","timestamp":1685375924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383509007307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0304383509007307"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2009.12.014","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}